FTO and obesity due to melanocortin 4 receptor deficiency: Further to its association with obesity, epidemiological studies link FTO SNPs with higher risks of endometrial cancer [74,75,76], breast cancer [77,78], pancreatic cancer [76,79,80] and melanoma [81]; with some variations among different races.